vs
Side-by-side financial comparison of Koppers Holdings Inc. (KOP) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $432.7M, roughly 1.4× Koppers Holdings Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs 6.9%, a 27.6% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -9.3%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -6.7%).
Koppers is a global chemical and materials company based in Pittsburgh, Pennsylvania, United States. Its headquarters is an art-deco 1920s skyscraper, the Koppers Tower.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
KOP vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $432.7M | $622.0M |
| Net Profit | $29.7M | $214.2M |
| Gross Margin | 25.6% | — |
| Operating Margin | 11.5% | 62.4% |
| Net Margin | 6.9% | 34.4% |
| Revenue YoY | -9.3% | 4.8% |
| Net Profit YoY | 391.2% | 2.9% |
| EPS (diluted) | $1.44 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $432.7M | $622.0M | ||
| Q3 25 | $485.3M | $609.3M | ||
| Q2 25 | $504.8M | $578.7M | ||
| Q1 25 | $456.5M | $568.2M | ||
| Q4 24 | $477.0M | $593.6M | ||
| Q3 24 | $554.3M | $564.7M | ||
| Q2 24 | $563.2M | $537.3M | ||
| Q1 24 | $497.6M | $568.0M |
| Q4 25 | $29.7M | $214.2M | ||
| Q3 25 | $23.8M | $288.2M | ||
| Q2 25 | $16.4M | $30.2M | ||
| Q1 25 | $-13.9M | $238.3M | ||
| Q4 24 | $-10.2M | $208.2M | ||
| Q3 24 | $22.8M | $544.0M | ||
| Q2 24 | $26.8M | $102.0M | ||
| Q1 24 | $13.0M | $4.8M |
| Q4 25 | 25.6% | — | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 22.6% | — | ||
| Q1 25 | 23.2% | — | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | 21.9% | — | ||
| Q2 24 | 21.6% | — | ||
| Q1 24 | 19.3% | — |
| Q4 25 | 11.5% | 62.4% | ||
| Q3 25 | 10.7% | 70.1% | ||
| Q2 25 | 7.7% | 36.3% | ||
| Q1 25 | 5.9% | 94.0% | ||
| Q4 24 | 1.3% | 60.9% | ||
| Q3 24 | 9.0% | — | ||
| Q2 24 | 10.2% | 50.2% | ||
| Q1 24 | 7.0% | -13.0% |
| Q4 25 | 6.9% | 34.4% | ||
| Q3 25 | 4.9% | 47.3% | ||
| Q2 25 | 3.2% | 5.2% | ||
| Q1 25 | -3.0% | 41.9% | ||
| Q4 24 | -2.1% | 35.1% | ||
| Q3 24 | 4.1% | 96.3% | ||
| Q2 24 | 4.8% | 19.0% | ||
| Q1 24 | 2.6% | 0.8% |
| Q4 25 | $1.44 | $0.49 | ||
| Q3 25 | $1.17 | $0.67 | ||
| Q2 25 | $0.81 | $0.07 | ||
| Q1 25 | $-0.68 | $0.55 | ||
| Q4 24 | $-0.47 | $0.46 | ||
| Q3 24 | $1.09 | $1.21 | ||
| Q2 24 | $1.25 | $0.23 | ||
| Q1 24 | $0.59 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $618.7M |
| Total DebtLower is stronger | $928.3M | $9.0B |
| Stockholders' EquityBook value | $574.0M | $9.7B |
| Total Assets | $1.9B | $19.6B |
| Debt / EquityLower = less leverage | 1.62× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
| Q4 25 | $928.3M | $9.0B | ||
| Q3 25 | $932.9M | $8.9B | ||
| Q2 25 | $977.5M | $8.0B | ||
| Q1 25 | $989.0M | $7.6B | ||
| Q4 24 | $939.5M | $7.6B | ||
| Q3 24 | $989.4M | $7.6B | ||
| Q2 24 | $1.0B | $7.6B | ||
| Q1 24 | $877.6M | $6.1B |
| Q4 25 | $574.0M | $9.7B | ||
| Q3 25 | $545.6M | $9.6B | ||
| Q2 25 | $526.8M | $9.5B | ||
| Q1 25 | $498.0M | $9.8B | ||
| Q4 24 | $488.7M | $10.3B | ||
| Q3 24 | $532.3M | $10.3B | ||
| Q2 24 | $509.2M | $9.8B | ||
| Q1 24 | $505.8M | $9.9B |
| Q4 25 | $1.9B | $19.6B | ||
| Q3 25 | $1.9B | $19.3B | ||
| Q2 25 | $1.9B | $18.3B | ||
| Q1 25 | $1.9B | $17.6B | ||
| Q4 24 | $1.9B | $18.2B | ||
| Q3 24 | $2.0B | $18.0B | ||
| Q2 24 | $1.9B | $17.7B | ||
| Q1 24 | $1.8B | $16.1B |
| Q4 25 | 1.62× | 0.92× | ||
| Q3 25 | 1.71× | 0.93× | ||
| Q2 25 | 1.86× | 0.84× | ||
| Q1 25 | 1.99× | 0.78× | ||
| Q4 24 | 1.92× | 0.74× | ||
| Q3 24 | 1.86× | 0.74× | ||
| Q2 24 | 1.97× | 0.78× | ||
| Q1 24 | 1.74× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.1M | $827.1M |
| Free Cash FlowOCF − Capex | $28.5M | — |
| FCF MarginFCF / Revenue | 6.6% | — |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | 1.52× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $67.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.1M | $827.1M | ||
| Q3 25 | $49.6M | $702.6M | ||
| Q2 25 | $50.5M | $364.0M | ||
| Q1 25 | $-22.7M | $596.1M | ||
| Q4 24 | $74.7M | $742.5M | ||
| Q3 24 | $29.8M | $703.6M | ||
| Q2 24 | $27.2M | $658.2M | ||
| Q1 24 | $-12.3M | $664.6M |
| Q4 25 | $28.5M | — | ||
| Q3 25 | $37.6M | — | ||
| Q2 25 | $38.4M | — | ||
| Q1 25 | $-37.0M | — | ||
| Q4 24 | $56.1M | — | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $-38.6M | — |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 7.6% | — | ||
| Q1 25 | -8.1% | — | ||
| Q4 24 | 11.8% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | -7.8% | — |
| Q4 25 | 3.8% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | 1.52× | 3.86× | ||
| Q3 25 | 2.08× | 2.44× | ||
| Q2 25 | 3.08× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 1.31× | 1.29× | ||
| Q2 24 | 1.01× | 6.45× | ||
| Q1 24 | -0.95× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KOP
| Other | $127.8M | 30% |
| Railroad Treated Products | $119.0M | 28% |
| Utility Poles | $79.8M | 18% |
| Pitch And Related Products | $74.1M | 17% |
| Carbon Black Feedstock And Distillates | $14.4M | 3% |
| Railroad Infrastructure Products And Services | $9.9M | 2% |
| Phthalic Anhydride Naphthalene And Other Chemicals | $7.7M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
